Chemotherapy-induced Diarrhea OverviewChemotherapy-induced diarrhea, also called chemotherapy-related diarrhea, is a common problem in cancer patients and is most often described with fluoropyrimidines, irinotecan, and several molecularly targeted agents. It can be debilitating and sometimes life-threatening; hospital admission is frequently needed for adequate supportive care. Chemotherapy-induced Diarrhea Epidemiology Insights (2022)<ul><li>The total Incident cases of Chemotherapy-induced Diarrhea in the 7MM were ~1 million in 2022</li><li>Lung cancer contributed to the highest number of cases in the US among selected major</li><li>Cancers.</li><li>In EU4 and the UK, colorectal cancer represented the second-highest number of incident cases in the United</li><li>In the US, ~60% of cancer incident cases receive chemotherapy.</li><li>Among the total incident cases, ~40% of cases develop Grade ≥3 Chemotherapy-induced Diarrhea</li></ul> <a href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chemotherapy-induced Diarrhea Epidemiology</a> Segmentation in the 7MM from 2019 to 2032<ul><li>Incident Cases of Selected Cancer Types</li><li>Total Patients on Chemotherapies by Cancer Types</li><li>Incident Cases of Chemotherapy-induced Diarrhea by Selected Cancer Types</li><li>Grade-specific Cases of Chemotherapy-induced Diarrhea</li><li>Total Treated Cases of Chemotherapy-induced Diarrhea</li></ul> Chemotherapy-induced Diarrhea Major Treatment Options<ul><li>Loperamide</li><li>Octreotide</li><li>Other anti-diarrheal therapies</li></ul> <a href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chemotherapy-induced Diarrhea Market</a> Insight (2022)<ul><li>The Chemotherapy-induced Diarrhea Market size was valued&nbsp; ~USD 80 million in the 7MM in 2022</li><li>The US accounted for the largest Chemotherapy-induced Diarrhea market size.</li></ul> <a href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-pipeline-insights" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Chemotherapy-induced Diarrhea Emerging Drugs</a> and Companies<ul><li>MYTESI: Napo Pharmaceuticals (Jaguar Health), and others</li></ul>

Chemotherapy Induced Diarrhea Market

Chemotherapy Induced Diarrhea Market Infographics

Chemotherapy Induced Diarrhea Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape